ZIRA: A new prognostic biomarker of estrogen receptor- positive (ER plus ) breast cancers

被引：0
|
作者：
Vendrell, J. [1 ]
Nguyen, N. T. [1 ]
Gyorffy, B. [3 ]
Leon, S. [2 ]
Grisard, E. [1 ]
Bachelot, T. [2 ]
Treilleux, I. [2 ]
Cohen, P. A. [1 ]
机构：
[1] Univ Lyon 1, Ctr Rech Cancerol Lyon, F-69365 Lyon, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Hungarian Acad Sci, Res Lab Pediat & Nephrol, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50569-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
649
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [1] Clinicopathological characteristics of estrogen receptor-β-positive human breast cancers
    Miyoshi, Y
    Taguchi, T
    Gustafsson, JÅ
    Noguchi, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (10): : 1057 - 1061
  • [2] A new class of estrogen receptor-α (ERα) inhibitors to treat tamoxifen-resistant breast cancers
    Singh, Kriti
    Munuganti, Ravi S. N.
    Butler, Miriam
    Leblanc, Eric
    Cherkasov, Artem
    Rennie, Paul S.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S19 - S19
  • [3] Mechanisms of estrogen receptor-α upregulation in breast cancers
    Miyoshi, Yasuo
    Murase, Keiko
    Saito, Masaru
    Imamura, Michiko
    Oh, Koushi
    MEDICAL MOLECULAR MORPHOLOGY, 2010, 43 (04) : 193 - 196
  • [4] Mechanisms of estrogen receptor-α upregulation in breast cancers
    Yasuo Miyoshi
    Keiko Murase
    Masaru Saito
    Michiko Imamura
    Koushi Oh
    Medical Molecular Morphology, 2010, 43 : 193 - 196
  • [5] UBE2C a poor prognostic biomarker in Black women with estrogen receptor positive (ER plus ) breast cancer in TCGA.
    Jones, Veronica
    Yuan, Yate-Ching
    Davis, Melissa
    Seewaldt, Victoria
    Kittles, Rick
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 253 - 254
  • [6] Inhibition of Estrogen Receptor Signaling as a Strategy for Radiosensitization of ER plus Breast Cancers
    Michmerhuizen, A. R.
    Pesch, A.
    Schwartz, R.
    Wilder-Romans, K.
    Liu, M.
    Harold, A.
    Azaria, R.
    Hayes, D.
    Rae, J.
    Pierce, L. J.
    Schmidt, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E253 - E253
  • [7] Inhibition of estrogen receptor signaling as a strategy for radiosensitization of ER plus breast cancers
    Michmerhuizen, Anna R.
    Lerner, Lynn M.
    Pesch, Andrea M.
    Ward, Connor
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Nino, Charles
    Jungles, Kassidy
    Azaria, Ruth
    Jelley, Alexa
    Garcia, Nicole Zambrana
    Harold, Alexis
    Zhang, Amanda
    Wharram, Bryan
    Hayes, Daniel F.
    Rae, James M.
    Pierce, Lori J.
    Speers, Corey W.
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers
    Kurbel, S
    MEDICAL HYPOTHESES, 2005, 64 (06) : 1182 - 1187
  • [9] Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
    Castellano, Isabella
    Allia, Elena
    Accortanzo, Valeria
    Vandone, Anna Maria
    Chiusa, Luigi
    Arisio, Riccardo
    Durando, Antonio
    Donadio, Michela
    Bussolati, Gianni
    Coates, Alan S.
    Viale, Giuseppe
    Sapino, Anna
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 607 - 617
  • [10] Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
    Isabella Castellano
    Elena Allia
    Valeria Accortanzo
    Anna Maria Vandone
    Luigi Chiusa
    Riccardo Arisio
    Antonio Durando
    Michela Donadio
    Gianni Bussolati
    Alan S. Coates
    Giuseppe Viale
    Anna Sapino
    Breast Cancer Research and Treatment, 2010, 124 : 607 - 617
12345